Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP23-001, Panel A, Assessing the Effectiveness of Programs, Policies, or Practices That Affect Social Determinants of Health To Promote Health Equity and Reduce Health Disparities in Chronic Diseases; Amended Notice of Closed Meeting, 10904-10905 [2023-03568]

Download as PDF 10904 Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices GENERAL SERVICES ADMINISTRATION [Notice–ME–2023–01; Docket No. 2023– 0002; Sequence No. 6] Notice of High-Performance Computing (HPC) Summit Office of Government-wide Policy (OGP), General Services Administration (GSA). ACTION: Virtual webinar meeting notice. AGENCY: GSA is hosting a virtual HighPerformance Computing (HPC) Summit to bring together the Federal and industry communities for a series of panel discussions covering HPC implementation progress, opportunities, and best practices. DATES: The meeting date is scheduled for Thursday, April 20, 2023. ADDRESSES: This is a virtual event. The call-in information will be made available upon registration. All attendees, including industry partners, must register for the Zoom.Gov event here: https://gsa.zoomgov.com/webinar/ register/WN_rIfNxEkdToWco5S2irse8w. Members of the press are invited to attend but are required to register with the GSA press office (via email press@ gsa.gov) by Thursday, April 13, 2023. FOR FURTHER INFORMATION CONTACT: Tom Santucci at thomas.santucci@gsa.gov or 202–230–4822 or Lee Ellis at lee.ellis@ gsa.gov or 202–253–6448. SUPPLEMENTARY INFORMATION: SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 Background The Executive Office of the President issued Executive Order (E.O.) 13702, titled, ‘‘Creating a National Strategic Computing Initiative’’ (80 FR 46177), and located at: https://www.govinfo.gov/ content/pkg/FR-2015-08-03/pdf/201519183.pdf, in August 2015 to maximize the benefits of High-Performance Computing (HPC). The potential opportunities of implementing HPC include improving economic competitiveness and accelerating scientific research. The E.O. includes the following five strategic objectives for supporting the implementation of HPC across all Federal information systems and services: (1) The United States must deploy and apply new HPC technologies broadly for economic competitiveness and scientific discovery. (2) The United States must foster public-private collaboration, relying on the respective strengths of government, industry, and academia to maximize the benefits of HPC. (3) The United States must adopt a whole-of-government approach that VerDate Sep<11>2014 19:42 Feb 21, 2023 Jkt 259001 draws upon the strengths of and seeks cooperation among all executive departments and agencies with significant expertise or equities in HPC while also collaborating with industry and academia. (4) The United States must develop a comprehensive technical and scientific approach to transition HPC research on hardware, system software, development tools, and applications efficiently into development and, ultimately, operations. More recently, agencies, such as the National Institute of Standards and Technology (NIST), have continued developing guidance and prioritizing HPC to combat growing cybersecurity threats. NIST Publication SP 800–23, https://csrc.nist.gov/publications/detail/ sp/800-223/draft, released in February 2023 as a draft, discusses HPC system threat analysis, security postures, challenges, and recommendations. The typical information technology (IT) practitioner knows very little about HPC. This summit will provide IT practitioners of any skill level with practical knowledge and insight into HPC as both an industry and a service, as well as how the Federal Government can use HPC now and in the future. Additional legislation, such as the bipartisan CHIPS Act of 2022, provides additional funding for both HPC research and development, as well as the standup of government programs on HPC at various agencies. The combination of Executive Orders, policies, and legislation create a comprehensive framework for the Federal Government to prioritize the adoption of High-Performance Computing to advance key IT Modernization efforts. Format The High-Performance Computing (HPC) Summit convenes leaders from the Federal Government and industry to discuss their experiences and exposures to HPC. If you have questions for the panelists, you can email them to the GSA Office of Government-wide Policy (OGP) IT Modernization Team at dccoi@ gsa.gov by Thursday, April 13, 2023. Special Accommodations Zoom will have the option to enable closed captioning. If additional accommodations are needed, please indicate on the Zoom Webinar registration form. Live Webinar Speakers (Subject To Change Without Notice) Hosted by: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 • Tom Santucci, Director, IT Modernization; Office of Governmentwide Policy • Robert Sears, Director, N-Wave, National Oceanic and Atmospheric Administration; Office of Chief Information Officer (CIO) • Gordon Bitko, Executive Vice President of Policy, Public Sector, Information Technology Industry Council (ITIC) • CIO Council Innovation Committee, tri-chaired by Ann Dunkin, CIO, Department of Energy; Chris Brazier, Chief Technology Officer & Mission IT Infrastructure & Services Department Chief, Defense Threat Reduction Agency; Chezian Sivagnanam, Chief Architect, Federal Deposit Insurance Corporation Agenda Topic Areas • Public Policy • Science and CHIPS Act • Climate • Energy • Biomedical • Military Thomas Santucci, Director, IT Modernization, General Services Administration, Office of Government-wide Policy, Division of IT Modernization. [FR Doc. 2023–03563 Filed 2–21–23; 8:45 am] BILLING CODE 6820–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP23–001, Panel A, Assessing the Effectiveness of Programs, Policies, or Practices That Affect Social Determinants of Health To Promote Health Equity and Reduce Health Disparities in Chronic Diseases; Amended Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP23– 001, Panel A, Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determinants of Health to Promote Health Equity and Reduce Health Disparities in Chronic Diseases; April 18, 2023, 10 a.m.–6 p.m., EDT, teleconference, in the original Federal Register notice. The meeting was published in the Federal Register on February 9, 2023, Volume 88, Number 27, page 8431. E:\FR\FM\22FEN1.SGM 22FEN1 Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices The meeting is being amended to change the meeting date and should read as follows: Date: April 21, 2023. Time: 10 a.m.–6 p.m., EDT. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Natalie Brown, M.P.H., Scientific Review Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop S107–8, Atlanta, Georgia 30341–3717; Telephone: (404) 639– 4601; Email: NBrown3@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–03568 Filed 2–21–23; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention lotter on DSK11XQN23PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE23– 004: Research Grants for Preventing Violence and Violence Related Injury; Amended Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CE23–004: Research Grants for Preventing Violence and Violence Related Injury; March 28–29, 2023, 8:30 a.m.–5:30 p.m., EDT, Videoconference, in the original FRN. The meeting was published in the Federal Register on January 20, 2023, Volume 88, Number 13, page 3743. The meeting is being amended to remove the second day and should read as follows: Date: March 29, 2023 Time: 8:30 a.m.–5:00 p.m. (EDT) Place: Videoconference. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for 19:42 Feb 21, 2023 Jkt 259001 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. 1905 Willowdale Road, Morgantown, West Virginia 26506; Telephone: (304) 285–5951; Email: MGoldcamp@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–03567 Filed 2–21–23; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2023–03565 Filed 2–21–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting BILLING CODE 4163–18–P VerDate Sep<11>2014 Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone: (404) 639–6473; Email: AWilkes@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 10905 Frm 00037 Fmt 4703 Sfmt 4703 Recharter for Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA OH–23–004, NIOSH Miner Safety and Health Program—Western Mining States Review; and RFA OH–23–005, NIOSH Robotic Mining Review. Date: May 25, 2023. Time: 1 p.m.–5 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific Review Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, PO 00000 Health Resources and Services Administration In accordance with the Federal Advisory Committee Act (FACA), the Department of Health and Human Services is hereby giving notice that the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has been rechartered. The effective date of the recharter is February 19, 2023. FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant (Designated Federal Officer); HRSA Division of Transplantation, HRSA, 5600 Fishers Lane, 08W67, Rockville, Maryland 20857; 301–443–8036; or sgrant@ hrsa.gov. SUPPLEMENTARY INFORMATION: The ACBSCT advises, assists, consults with, and makes recommendations to the Secretary of Health and Human Services, acting through the HRSA Administrator, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory and other matters of significance concerning the activities under section 379 of the Public Health Service Act (42 U.S.C. 274k). The ACBSCT shall provide a consolidated, comprehensive source of expert, unbiased analysis, and recommendations to the Secretary of Health and Human Services on the latest advances in the science of blood SUMMARY: E:\FR\FM\22FEN1.SGM 22FEN1

Agencies

[Federal Register Volume 88, Number 35 (Wednesday, February 22, 2023)]
[Notices]
[Pages 10904-10905]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03568]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--DP23-001, Panel A, Assessing the Effectiveness of 
Programs, Policies, or Practices That Affect Social Determinants of 
Health To Promote Health Equity and Reduce Health Disparities in 
Chronic Diseases; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--DP23-001, Panel A, Assessing the Effectiveness of Programs, 
Policies, or Practices that Affect Social Determinants of Health to 
Promote Health Equity and Reduce Health Disparities in Chronic 
Diseases; April 18, 2023, 10 a.m.-6 p.m., EDT, teleconference, in the 
original Federal Register notice. The meeting was published in the 
Federal Register on February 9, 2023, Volume 88, Number 27, page 8431.

[[Page 10905]]

    The meeting is being amended to change the meeting date and should 
read as follows:

Date: April 21, 2023.
Time: 10 a.m.-6 p.m., EDT.

    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Natalie Brown, M.P.H., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-8, Atlanta, 
Georgia 30341-3717; Telephone: (404) 639-4601; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-03568 Filed 2-21-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.